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Exogenous phospholipase D generates lysophosphatidic acid
and activates Ras, Rho and Ca2+ signaling pathways
Marc CM van Dijk, Friso Postma, Henk Hilkmann, Kees Jalink, Wim J van
Blitterswijk and Wouter H. Moolenaar
Background: Phospholipase D (PLD) hydrolyzes phospholipids to generate
phosphatidic acid (PA) and a free headgroup. PLDs occur as both intracellular
and secreted forms; the latter can act as potent virulence factors. Exogenous
PLD has growth-factor-like properties, in that it induces proto-oncogene
transcription, mitogenesis and cytoskeletal changes in target cells. The
underlying mechanism is unknown, although it is generally assumed that PLD
action is mediated by PA serving as a putative second messenger. 
Results: In quiescent fibroblasts, exogenous PLD (from Streptomyces
chromofuscus) stimulated accumulation of the GTP-bound form of Ras,
activation of mitogen-activated protein (MAP) kinase and DNA synthesis,
through the pertussis-toxin-sensitive inhibitory G protein Gi. Furthermore, PLD
mimicked bioactive lysophospholipids (but not PA) in inducing Ca2+
mobilization, membrane depolarization and Rho-mediated neurite retraction.
PLD action was mediated by lysophosphatidic acid (LPA) derived from
lysophosphatidylcholine acting on cognate G-protein-coupled LPA receptor(s).
There was no evidence for the involvement of PA in mediating the effects of
exogenous PLD. 
Conclusions: Our results provide a molecular explanation for the multiple
cellular responses to exogenous PLDs. These PLDs generate bioactive LPA
from pre-existing lysophosphatidylcholine in the outer membrane leaflet,
resulting in activation of G-protein-coupled LPA receptors and consequent
activation of Ras, Rho and Ca2+ signaling pathways. Unscheduled activation of
LPA receptors may underlie, at least in part, the known pathogenic effects of
exogenous PLDs.
Background
Phospholipase D (PLD) hydrolyzes phospholipids to gen-
erate phosphatidic acid (PA) and the relevant headgroup.
PLDs occur in both intracellular and secreted forms.
Whereas intracellular PLD has been implicated in eukary-
otic signal transduction and membrane traffic [1–3], PLDs
secreted by bacteria can act as potent virulence factors
[4–7]. A pathogenic PLD enzyme, which hydrolyzes lyso-
phosphatidylcholine (LPC) and sphingomyelin, is also
found in spider venom [4,7–9]. Although they arise in
diverse organisms, exogenous PLDs evoke similar clinical
effects, notably severe inflammatory responses, platelet
aggregation and an increase in vascular permeability,
without evidence for a purely cytotoxic effect [4,6–10]. In
no case is the molecular basis for pathogenesis known [4].
When added to cultured mammalian cells, bacterial PLD
(from Streptomyces chromofuscus) mimics hormones and
growth factors in inducing such diverse responses as Ca2+
mobilization, muscle contraction, c-fos and c-myc proto-
oncogene transcription, protein tyrosine phosphorylation,
secretion, actin polymerization and DNA synthesis
[11–17]. The underlying signaling mechanism is not
understood, although it is generally believed that PLD
action is mediated by PA serving as a putative second
messenger [11–17]. Although PA may modulate certain
enzyme activities in vitro [1,2], no molecular target of PA
has been rigorously defined to date.
In the present study, we have re-examined the signaling
mechanisms activated in response to exogenous PLD.
We found that PLD acts by producing bioactive lyso-
phosphatidic acid (LPA) [18] from pre-existing LPC in
the outer leaflet of the plasma membrane. Newly pro-
duced LPA then activates its cognate G-protein-coupled
receptor(s) to trigger the signaling cascades mediated by
Ras, Rho and phospholipase C (PLC); there is no need to
invoke a signaling role for PA produced at the outer
membrane leaflet. Our results solve the long-standing
question of how exogenous PLD activates mammalian
cells, and they provide a biochemical basis for its known
pathogenic effects.
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Results and discussion
To determine how exogenous PLD activates quiescent
cells, we analyzed changes in mitogenic signaling path-
ways, the cytoskeleton, Ca2+ mobilization and electro-phys-
iological responses in PLD-treated cells. We also analyzed
PLD-induced phospholipid metabolism in these cells.
Gi-mediated mitogenic signaling
When added to serum-deprived Rat-1 cells, PLD (from
S. chromofuscus [19]) evoked a significant mitogenic
response (Figure 1). In contrast, exogenous phospholi-
pase C (PC-PLC from Bacillus cereus), which generates
diacylglycerol from phosphatidylcholine (PC) [20], failed
to induce DNA synthesis in these cells (Figure 1; see
also [20]). The kinetics of PLD-induced DNA synthesis
are similar to those observed with growth factors, with S-
phase entry starting after about 8 hours from the start of
induction; there was no sign of long-term cytotoxicity. As
shown in Figure 1, PLD-induced DNA synthesis is
almost completely inhibited by pertussis toxin (PTX),
indicating a key role for a heterotrimeric G protein of the
Gi subfamily. 
Mitogenic agonists that signal through Gi rapidly activate
the Ras GTPase [21] and the downstream Raf and
mitogen-activated protein (MAP) kinase cascade. We mea-
sured the activation state of Ras in Rat-1 cells using two
distinct assays: Ras–GTP accumulation and stimulation of
the Ras–Raf interaction. Figure 2 shows that PLD treat-
ment of quiescent Rat-1 cells leads to Ras activation
within minutes. Similar Ras activation was observed in
response to LPA, but not PA (Figure 2) [21]. Pretreatment
of the cells with PTX inhibited Ras activation in response
to PLD and LPA, but not epidermal growth factor (EGF)
(Figure 2) [21]. 
As shown in Figure 3a, PLD-induced Ras activation was
followed by a long-lasting (over 4 hours) activation of
MAP kinase (p42/p44 ERK) in a PTX-sensitive manner.
In contrast, non-mitogenic PC-PLC failed to activate Ras
(Figure 2) and induced only transient (less than 1 hour)
Figure 1
PLD-induced DNA synthesis in Rat-1 cells. Thymidine incorporation
(an indicator of DNA synthesis) was measured as a function of time.
Serum-deprived cells were exposed to PLD (derived from S.
chromofuscus; 5 U/ml), in the absence or presence of PTX
(200 ng/ml), or to PC-PLC (derived from B. cereus; 1 U/ml), as
indicated. Error bars represent SD (n = 4).
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Figure 2
Ras activation. (a) Accumulation of the GTP-bound form of Ras
(Ras–GTP) as a function of time. Cells labeled with 32P were
stimulated for 5 min with PLD (5 U/ml), PC-PLC (1 U/ml) or LPA
(1 µM), and the guanine nucleotides bound to immunoprecipitated Ras
were assayed (see Materials and methods). Error bars indicate s.e.m.
(n = 3). (b) Detection of the GTP-bound form of Ras using a
glutathione-S-transferase (GST) fusion protein containing the minimal
Ras-binding domain (RBD) of Raf1. Rat-1 cells were stimulated for
2 min with EGF (10 ng/ml), LPA (1 µM) or PLD (5 U/ml) in the
presence or absence of PTX (200 ng/ml; overnight pretreatment) as
indicated. Ras was identified by precipitation using the GST–RBD
fusion protein followed by immunoblotting using anti-Ras antibody
Y13–259. Control indicates no addition. 
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MAP kinase activation, which was insensitive to PTX
(Figure 3a) and is thought to be mediated by protein
kinase C-ζ [20]. These kinetics are consistent with mito-
genesis requiring sustained rather than transient MAP
kinase activation [22]. Collectively, these results strongly
suggest that exogenous PLD acts through a Gi-coupled
receptor to stimulate the Ras–Raf–MAP kinase cascade
and ensuing DNA synthesis. Obviously, the most likely
candidate is the LPA receptor, which is present in numer-
ous cell types [18]. 
Cross-desensitization experiments
To examine the possibility that PLD acts through activa-
tion of LPA receptors, we carried out cross-desensitization
experiments by monitoring MAP kinase activation and
acute ionic responses to both LPA and PLD, notably Ca2+
mobilization and membrane depolarization. As shown in
Figure 3b, LPA pretreatment of Rat-1 cells blocked PLD-
induced MAP kinase activation, and vice versa, whereas
EGF-induced MAP kinase activation was not affected by
either pretreatment. 
Figure 4a shows that PLD mimics LPA in evoking a rapid,
transient Ca2+ signal in Rat-1 cells. Similar Ca2+ transients
were observed in PLD-treated human diploid fibroblasts,
A431 carcinoma cells and N1E-115 neuroblastoma cells
([12] and data not shown). PLD-induced Ca2+ mobiliza-
tion is accompanied by enhanced inositol phosphate pro-
duction [12], indicative of PLC activation. As shown in
Figure 4a, prior addition of LPA prevented the Ca2+-
mobilizing action of PLD and vice versa, which supports
the view that PLD acts through LPA receptors. In con-
trast, no such cross-desensitization was observed between
the Ca2+-mobilizing action of PLD and that of the
lysosphingolipid sphingosine-1-phosphate (S1P), which
acts on a distinct G-protein-coupled receptor [23,24] (data
not shown). This finding rules out the possibility that
PLD acts through S1P receptors. 
LPA also evokes a transient membrane depolarization in
target cells, which is caused by opening of a Cl– channel
[25] and accompanies Rho activation (F. Postma, W.H.M.,
unpublished observations). Figure 4b shows that PLD
fully mimics LPA in evoking a transient inward current,
reflecting membrane depolarization, in serum-deprived
N1E-115 neuronal cells. LPA pretreatment desensitized
the PLD-induced inward current, but not that induced by
a thrombin receptor peptide agonist (TRP; Figure 4b) or
S1P (data not shown). Conversely, PLD treatment inhib-
ited the subsequent response to LPA (Figure 4b). None of
the above ionic responses (Ca2+ mobilization and mem-
brane depolarization) can be evoked by exogenously added
PA, provided it is free of LPA contamination [25,26]. Col-
lectively, the cross-desensitization experiments show that
exogenous PLD signals through LPA receptors.
PLD mimics LPA in inducing Rho-mediated cytoskeletal
contraction 
We also examined the extent to which PLD mimics LPA
in inducing rapid cytoskeletal contraction, using N1E-115
neuronal cells as a model. When treated with LPA or S1P,
these cells undergo acute growth-cone collapse, neurite
withdrawal and rounding of the cell body, caused by con-
traction of the actomyosin-based cytokeleton [24,27–29].
These dramatic shape changes are driven by the Ras-
related Rho GTPase [24,28,29], a key regulator of the
actin cytoskeleton [30]. As summarized in Table 1, exoge-
nous PLD evoked neuronal shape changes that were
388 Current Biology, Vol 8 No 7
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MAP kinase activation. (a) Cells were stimulated for different periods
of time with PLD (5 U/ml) or PC-PLC (1 U/ml), and total cell lysates
were immunoblotted with anti-p42 MAP kinase antibodies that
recognize the p42 and p44 isoforms of MAP kinase. Activated
(phosphorylated) forms of MAP kinase (pp42 and pp44) show
reduced electrophoretic mobility. (b) Sensitivity of PLD-induced MAP
kinase activation to PTX (200 ng/ml; cells were stimulated with PLD for
10 min). Note that the response to PC-PLC is resistant to PTX.
(c) Cross-desensitization. Activation of p42 MAP kinase induced by
LPA (1 µM), PLD (5 U/ml) or EGF (10 ng/ml) in quiescent Rat-1 cells,
compared with the response in cells preincubated for 30 min with
either PLD or LPA. MAP kinase mobility shift was measured 10 min
indistinguishable from those induced by LPA; these
effects were blocked by the Rho-inactivating C3 exotoxin.
In contrast, no detectable shape changes were induced by
addition of either PC-PLC (Table 1) or purified, LPA-free
PA [27]. From these results, we conclude that exogenous
PLD acts on LPA receptors to activate Rho signaling.
Consistent with this, an earlier study has shown that
exogenous PLD mimics LPA, rather than PA, in inducing
Rho-mediated invasion of tumor cells in vitro [31,32]. 
PLD produces LPA from LPC 
Having shown that exogenous PLD signals through LPA
receptors, we next examined how LPA might be gener-
ated. First, we ruled out the formal possibility that PLD
action is due to contaminating traces of LPA (or other
bioactive lipids) by establishing that all cellular responses
to PLD (but not those to LPA) were abolished after boiling
the enzyme (data not shown). Next, we measured produc-
tion of both PA and LPA in PLD-treated Rat-1 cells using
two-dimensional thin layer chromatography (TLC). As
shown in Figure 5a, PLD treatment of 32P-labeled cells
resulted in the rapid formation of PA and, to a lesser
extent, LPA (relative increases were 11.1-fold and 3.3-fold,
respectively). The newly produced LPA could arise either
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Figure 4
Ionic responses to PLD (1 U/ml), LPA (1 µM)
and TRP (100 µg/ml). (a) Ca2+ mobilization in
Rat-1 cells loaded with the fluorescent Ca2+
indicator Indo-1. F, fluorescence. (b)
Electrophysiological recordings from single,
serum-deprived N1E-115 neuronal cells using
the perforated patch-clamp method (see
Materials and methods). Agonist-induced
inward currents represent Cl–-mediated
membrane depolarization [25]. Current pulses
in the lower recording reflect monitoring of
membrane conductance.
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Table 1
PLD-induced and LPA-induced morphological changes in
N1E-115 cells.
Treatment Neurite retraction/cell rounding
LPA (0.5 µM) ++
PLD (1 U/ml) ++
PC-PLC (1 U/ml) –
C3 exotoxin + PLD –
C3 exotoxin + LPA –
N1E-115 cells were incubated for 24 h in serum-free medium to
induce cell flattening and neurite outgrowth [27,28]. Agonists were
added and the cells were observed for shape changes [27]: ++,
complete neurite retraction and cell rounding in > 90% of the flattened
cells within 3 min; –, no detectable shape changes within 10 min. The
Rho-inactivating C3 exotoxin (10 µg/ml) [28] was added 12 h prior to
addition of PLD or LPA. The indicated responses were consistently
observed in at least 12 separate experiments.
from deacylation of PA (through phospholipase A2 activ-
ity) or, more directly, through hydrolysis of pre-existing
LPC. Regarding the latter possibility, we note that LPC
might represent up to a few percent of total phospholipids
in the plasma membrane, where it localizes preferentially
to the outer leaflet [33–35]. Figure 5a shows that PLD-
induced LPA formation was accompanied by a marked
decrease in LPC, consistent with LPC serving as a precur-
sor of LPA. 
To further substantiate this precursor–product relation-
ship, Rat-1 cells were incubated with [32P]LPC, which
readily inserts into the outer leaflet of the plasma mem-
brane. PLD treatment of such [32P]LPC-labeled cells
390 Current Biology, Vol 8 No 7
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Phospholipid analysis of PLD-treated Rat-1 cells. (a) Two-dimensional
TLC analysis of 32P-labelled cells before and after treatment with PLD
(5 U/ml) for 5 min. Note the appearance of LPA at the expense of LPC.
Quantitative analysis revealed that PA levels increased 11.1-fold and
LPA levels increased 3.3-fold after PLD treatment for 5 min. (b) TLC
analysis of [32P]LPC-labeled cells before and after treatment with PLD
for 5 min, as indicated. CHCl3, organic phase; H2O, water phase. Note
the appearance of LPA at the expense of LPC (water phase), whereas
the radiolabeled PC pool remains unaltered (the latter pool is not
accessible to PLD, as explained in the text).
Figure 6
LPC-induced responsiveness to PLD in PLD-
resistant COS-7 cells. The concentration of
free Ca2+ in the cytosol (F) was monitored in
Indo-1-loaded cells. Note that the lack of
response to PLD was overcome after LPC
pretreatment (15 min incubation with 10 µM
LPC at 37°C, followed by removal of LPC
prior to stimulation with PLD and LPA).F
LPALPAPLD PLD
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No LPC pretreatment LPC pretreatment
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caused significant production of LPA at the expense of
LPC (Figure 5b; note that PLD does not significantly
affect the 32P-labeled PC pool because this pool is local-
ized to the cytosolic side of the plasma membrane and/or
intracellular membranes, where it is generated through co-
enzyme-A-dependent acylation of [32P]LPC [32]). 
From these results, we conclude that, in addition to pro-
ducing PA, PLD generates bioactive LPA through hydrol-
ysis of LPC present in the outer leaflet of the plasma
membrane. Newly produced LPA then activates its
cognate G-protein-coupled receptor(s) [18]. Receptor acti-
vation might occur through lateral diffusion of LPA within
the plane of the plasma membrane, because PLD-gener-
ated LPA was not detectable in the medium (data not
shown). Further work is required to test this notion.
Unresponsiveness to PLD is overcome by LPC
pretreatment
When testing various cell types for PLD-induced Ca2+
mobilization, we unexpectedly observed that COS-7
epithelial cells failed to respond to PLD, whereas they did
respond to LPA. We reasoned that such resistance to PLD
might be due to limited substrate availability and, if so,
should be overcome by artificially enriching the plasma
membrane with LPC. Indeed, pretreatment of COS-7
cells with exogenous LPC renders them fully responsive
to PLD, as measured by Ca2+ mobilization (Figure 6).
This result reinforces the notion that exogenous PLD acts
by producing LPA from LPC, and strongly suggests that
resistance to PLD is due to limited substrate availability
in the outer membrane leaflet.
Conclusions
Our results show that the multiple cellular effects of exoge-
nous PLD are elicited through activation of the G-protein-
coupled LPA receptor(s), and that the widely held belief
that newly produced PA is the primary mediator of the
actions of exogenous PLD [11–17] is incorrect. Our data do
not, of course, rule out the possibility that PA produced
intracellularly by endogenous PLDs does have an as-yet
unknown signaling function. There is an unequivocal role
for bacterial and spider venom PLDs in the pathogenesis of
disease, but the molecular basis for pathogenesis has been
elusive to date [4]. Unscheduled activation of LPA recep-
tors and consequent triggering of signaling cascades medi-
ated by Ras, Rho and PLC, as shown here, may well
account, at least in part, for the pathophysiological effects of
PLD, which include inflammation, increased vascular per-
meability and platelet aggregation, and which overlap with
the known biological responses to LPA [18]; it should be
kept in mind, however, that exogenous PLDs may also gen-
erate sphingomyelin-derived messengers in addition to
LPA. Future studies should examine the importance of the
PLD/LPA receptor signaling system in the pathogenesis of
bacterial disease. 
Materials and methods
Materials
Phospholipids were obtained from either Sigma or Serdary Research
Laboratories (London, Ontario). PLD (type VI; S. chromofuscus) was
from Sigma, and PC-PLC (B. cereus) from Boehringer Mannheim. PTX
and C3 exotoxin were from List laboratories. The GST–RafRBD fusion
construct was obtained from J.L. Bos (Utrecht University).
DNA synthesis
Confluent, serum-deprived Rat-1 cells in 24-well culture plates were
treated with agonists and exposed to [3H]thymidine (0.5 µCi/ml) for
various periods of time. Acid-precipitable material was dissolved in
0.1 M NaOH and quantified by liquid-scintillation counting.
Ras activation assays
Nearly confluent Rat-1 cells in six-well tissue culture plates were
serum-starved overnight, labeled for 3 h in phosphate-free minimum
essential medium (MEM) supplemented with 100 µCi/ml 32Pi, stimu-
lated with agonists and washed with ice-cold PBS. Cells were lysed in
1% Triton X-114 buffer, and p21ras was immunoprecipitated with mon-
oclonal Y13–259 precoupled via rabbit anti-rat IgG to protein
A–Sepharose and then assayed for bound guanine nucleotides by TLC
separation using polyethyleneimine-cellulose plates as described [21].
The amount of 32P in the GDP and GTP spots was quantified using a
Phosphoimager. In an alternative non-radioactive assay, we used the
minimal Ras-binding domain (RBD) of Raf1 (amino acids 51–131) to
identify activated Ras–GTP [33]. Ras was detected by precipitation
with GST–RBD fusion protein followed by immunoblotting using mono-
clonal Y13–259 as described in [36]. 
MAP kinase activation assays
Activation of p42MAPK and p44MAPK was determined by mobility-shift
assay. Stimulated Rat-1 cells were washed with cold PBS and lysed in
SDS sample buffer. Proteins were separated by SDS–PAGE (10%
acrylamide, 0.4% bisacrylamide gel) and transferred to nitrocellulose
membranes. These were blocked for 30 min with 5% milk powder in
TBST (10 mM Tris–HCl, pH 8.0; 150 mM NaCl containing 0.05% (v/v)
Tween-20), incubated with anti-p42MAPK (ERK2) antibodies, washed in
TBST and subsequently incubated with peroxidase-conjugated swine
anti-rabbit antibody. Immuno-stained antibodies were visualized by
enhanced chemiluminescence (Amersham).
Ca2+ mobilization
Confluent cells, grown on glass coverslips, were loaded with the
fluorescent Ca2+ indicator Indo-1, and Ca2+-dependent fluorescence
was monitored as described [26].
Electrophysiology
Electrophysiological recordings were obtained from N1E-115 cells
grown in 3 cm dishes using the whole-cell, perforated patch-clamp
technique with amphotericin in the pipette solution, as described [25].
Micropipettes were fire-polished and filled with a high K+, low Ca2+
buffer [23]. Data were collected using an EPC-7 amplifier (List-
Medical), interfaced to a personal computer via an A/D converter (TL-1
DMA interface, Axon Instruments Inc.). Voltage-clamp protocols were
generated, data were stored and analyzed using pClamp 6.0 (Axon
Instruments Inc.).
Phospholipid analysis
[32P]LPC was prepared by metabolic labeling of Rat-1 cells with 32Pi
for 20 h in MEM. Lipids were extracted [37] and separated by two-
dimensional TLC as follows: two runs in the first dimension (chloro-
form/methanol/7 N ammonia: 60:60:5, v/v) with intermittent drying,
followed by one run in the second dimension (chloroform/methanol/
acetic acid/water: 50:30:8:4 (v/v)). The PC spot was scraped off and
incubated in 0.5 ml 50 mM Tris/HCl pH 7.6, 1 mM Na deoxycholate,
10 mM MgCl2 containing 50 units PLA2 for 2 h at 37°C. Lipids were
extracted and [32P]LPC was isolated by one-dimensional TLC using
chloroform/methanol/acetic acid/water: 50:30:8:4 (v/v) (two runs). For
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analysis of PA/LPA generation in vivo, serum-starved Rat-1 cells were
labeled with [32P]lysoPC (10 µCi; 3 h) or with 32Pi (50 µCi; 20 h), and
then stimulated with PLD for 10 min. Cellular lipids were extracted,
separated by one-dimensional or two-dimensional TLC (see above) and
identified using comigrating marker lipids.
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